Highlights I'rom Group Co., Ltd.

Equities

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-05-28 EDT			5-day change	1st Jan Change
2,784 ^JPY	0.00%		+0.07%	+38.58%

2023	I'rom Group Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023	CI
2022	Lupin Ties Up with I'rom Group to Commercialize Denosumab in Japan	MT

Final dividend	03-27	FA
Ex-dividend day for interim dividend	23-09-27	FA
I'rom Group Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-11	CI
Ex-dividend day for extraordinary dividend	23-03-29	FA
Final dividend	23-03-29	FA
Ex-dividend day for interim dividend	22-09-28	FA
Lupin Ties Up with I'rom Group to Commercialize Denosumab in Japan	22-08-25	MT
Lupin and I'rom Enter into an Exclusive Licensing Agreement for Denosumab Biosimilar for Japan	22-08-25	CI
Ex-dividend day for final dividend	22-03-29	FA
Anniversary bonus dividend	22-03-29	FA
Ex-dividend day for interim dividend	21-09-28	FA
I'rom Group Co., Ltd. Announces Dividend for the Fiscal Year Ended March 31, 2021, Payable June 29, 2021 and Provided Dividend Guidance for the Second Quarter and Fiscal Year 2022	21-05-10	CI
Ex-dividend day for final dividend	21-03-29	FA
Ex-dividend day for interim dividend	20-09-28	FA
Ex-dividend day for final dividend	20-03-29	FA
I'rom Group Co., Ltd. Reports Consolidated Earnings Results for the Nine Months Ended December 2019; Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 2020; Provides Year End Dividend for the Year Ending March 31, 2020	20-02-05	CI
Ex-dividend day for interim dividend	19-09-26	FA
Ex-dividend day for final dividend	19-03-26	FA
Tranche Update on I'rom Group Co., Ltd.'s Equity Buyback Plan announced on February 26, 2019.	19-03-06	CI
I'rom Group Co., Ltd.'s Equity Buyback announced on February 26, 2019 has expired with 124,300 shares for ¥199.89 million.	19-03-04	CI

No results for this search